Analyst Ratings for Adventrx Pharmaceuticals (ANX)
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 11/27/2012 | Dawson James | N/A | New Coverage | Buy (N/A) |
2.00 (N/A) |
0.63 (0.73) |
15.87% | Details |
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 11/27/2012 | Dawson James | N/A | New Coverage | Buy (N/A) |
2.00 (N/A) |
0.63 (0.73) |
15.87% | Details |